0001144204-12-020832.txt : 20120410 0001144204-12-020832.hdr.sgml : 20120410 20120410080136 ACCESSION NUMBER: 0001144204-12-020832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120405 FILED AS OF DATE: 20120410 DATE AS OF CHANGE: 20120410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FECZKO JOSEPH M CENTRAL INDEX KEY: 0001319874 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 12750737 MAIL ADDRESS: STREET 1: PFIZER INC ATTN CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 4 1 v308866_4.xml OWNERSHIP DOCUMENT X0305 4 2012-04-05 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001319874 FECZKO JOSEPH M C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 1 0 0 0 Common Stock 2012-04-05 4 P 0 20000 1.62 A 70000 D Of the 70,000 shares, 18,333 are shares of restricted stock. /s/ James F. Oliviero, III, Attorney-in-Fact 2012-04-09